1. Cost-effectiveness of peer-delivered HIV self-tests for MSM in Uganda
- Author
-
Oucul Lazarus, Rachel King, Andrew Mujugira, Lung Vu, Barbara Castelnuovo, Sam Kalibala, Jean-Pierre Van Geertruyden, Perez Nicholas Ochanda, Yvonne Kamara, Stephen Okoboi, BONIZEC, Sandrine, Infectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda, Universiteit Antwerpen = University of Antwerpen [Antwerpen], Global Health Institute, Clarke International University, Kampala, Uganda., The AIDS Support Organization (TASO), Kampala, Uganda., Population Council, Washington, DC, United States, Department of Global Health, University of California, San Francisco, San Francisco, CA, United States, School of Public Health, Makerere University, Kampala, Uganda., Pathogenesis and Control of Chronic and Emerging Infections (PCCEI), and Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)-Université des Antilles (UA)-Etablissement français du don du sang [Montpellier]
- Subjects
Male ,Marginal cost ,HIV Positivity ,Cost effectiveness ,[SDV]Life Sciences [q-bio] ,Cost-Benefit Analysis ,Population ,Human immunodeficiency virus (HIV) ,HIV Infections ,Pilot Projects ,030312 virology ,medicine.disease_cause ,Sexual and Gender Minorities ,03 medical and health sciences ,0302 clinical medicine ,Acquired immunodeficiency syndrome (AIDS) ,Intervention (counseling) ,Environmental health ,medicine ,Humans ,Uganda ,MSM ,030212 general & internal medicine ,Homosexuality, Male ,education ,cost-effectiveness ,Africa South of the Sahara ,health care economics and organizations ,Original Research ,0303 health sciences ,education.field_of_study ,business.industry ,Transmission (medicine) ,lcsh:Public aspects of medicine ,Public Health, Environmental and Occupational Health ,HIV ,virus diseases ,lcsh:RA1-1270 ,medicine.disease ,peers ,[SDV] Life Sciences [q-bio] ,Public Health ,Human medicine ,business ,self-testing - Abstract
Introduction: Distribution of HIV self-testing (HIVST) kits through MSM peer networks is a novel and effective strategy to increase HIV testing coverage in this high-risk population. No study has evaluated the cost or cost effectiveness of peer distribution of HIVST strategies among MSM in sub-Saharan Africa.Methods: From June to August 2018, we conducted a pilot study of secondary MSM peer HIVST kit distribution at The AIDS Support Organization at Entebbe and Masaka. We used an ingredients approach to estimate the cost of MSM peer HIVST kit distribution relative to standard-of-care (SOC) hotspot testing using programme expenditure data reported in US dollars. The provider perspective was used to estimate incremental cost-effective ratios per HIV infection averted using the difference in HIV annual transmission rates between MSM with HIV who knew their status and were not virologically suppressed and MSM with HIV who did not know their status.Results: We enrolled 297 participants of whom 150 received MSM peer HIVST kit distribution (intervention group) and 147 received TASO standard of care HIV testing (control group). Provider cost for the intervention was $2,276 compared with $1,827 for SOC during the 3-month study period. Overall, the intervention resulted in higher HIV positivity yield (4.9 vs. 1.4%) and averted more HIV infections per quarter (0.364 vs. 0.104) compared with SOC. The cost per person tested was higher for the intervention compared to SOC ($15.90 vs. $12.40). Importantly, the cost per new HIV diagnosis ($325 vs. $914) and cost per transmission averted ($6,253 vs. $ 17,567) were lower for the intervention approach relative to SOC. The incremental cost per HIV transmission averted by the self-testing program was $1,727. The incremental cost to providers per additional HIV-positive person identified by the intervention was $147.30.Conclusion: The intervention strategy was cost-effective, and identified more undiagnosed HIV infections than SOC hotspot testing at a cost-effectiveness threshold of US $2,129. Secondary distribution of HIVST kits through peers should further be evaluated with longer duration aimed at diagnosing 95% of all persons with HIV by 2030; the first UNAIDS 95-95-95 target.
- Published
- 2021
- Full Text
- View/download PDF